Lv51
1044 积分 2021-03-19 加入
Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs
8天前
已完结
Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins
10天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
10天前
已完结
Targeting cancer with small-molecule pan-KRAS degraders
17天前
已完结
Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature
1个月前
已完结
Interleukin-13: Central Mediator of Allergic Asthma
1个月前
已完结
A druggable redox switch on SHP1 controls macrophage inflammation
2个月前
已完结
Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
2个月前
已完结
Oral ritlecitinib for the treatment of refractory vitiligo: A retrospective study
3个月前
已完结
Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial
3个月前
已关闭
皖公网安备34019202002308
